The Mesothelioma Center News – Page 24
-
Treatment & DoctorsMillions of people across the United States have begun receiving their COVID-19 vaccines, and restrictions are lifting in many public spaces such as restaurants…
-
Treatment & Doctors
Thoracic Surgeon Raja Flores Enters NYC Mayor’s Race
Thoracic surgeon and mesothelioma specialist Dr. Raja Flores wants to continue serving others, but in a new role as the next mayor… -
Research & Clinical Trials
Some Mesothelioma Patients May Benefit from Second Radical Surgery
As overwhelming as major surgery for malignant pleural mesothelioma can be, there is a small cohort of patients who still would benefit from… -
Asbestos Exposure & Bans
U.S. Asbestos Imports Increased Significantly in 2020
An estimated 300 metric tons of raw chrysotile asbestos was imported into the U.S. in 2020, almost doubling the amount from 2019, according to… -
Research & Clinical Trials
New Link Between Women with Mesothelioma and Survival Genes
Men with mesothelioma outnumber women four to one. However, numerous studies have shown that women with mesothelioma often have a survival advantage… -
Asbestos Exposure & Bans
Legal Fight Continues Over Asbestos Disease in Libby, Mont.
The Center for Asbestos Related Disease in Libby, Montana, dodged a potential setback recently when officials from the U.S. Department of Justice decided against… -
Legislation & Litigation
Johnson & Johnson Preparing $3.9 Billion for Talc Settlements
Pharmaceutical giant Johnson & Johnson has set aside $3.9 billion for talc-related litigation, according to a regulatory filing this week with the Securities and… -
Research & Clinical Trials
Study: Which Mesothelioma Patients Will Immunotherapy Benefit?
Thoracic surgeon Dr. Bryan Burt at the Baylor College of Medicine wants to better identify which patients with pleural mesothelioma cancer will benefit (and… -
Treatment & Doctors
Winter Storm Delays Cancer Treatment Across U.S.
Severe winter storms have affected multiple central U.S. states with power outages and water supply disruptions. State officials in Texas, Louisiana and Mississippi say… -
Research & Clinical Trials
FDA Fast-Tracks Mesothelioma Vaccine Development
The U.S. Food and Drug Administration has granted Fast-Track Designation this week to ONCOS-102, an immunotherapy vaccine that targets malignant mesothelioma and other hard-to-treat tumors.